Institutional Trading Of Harrow Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Institutional trading of harrow health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Institutional Trading Of Harrow Health Today - Breaking & Trending Today

Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […] ....

Craig Hallum , Institutional Trading Of Harrow Health , Eton Pharmaceuticals Inc , Harrow Health , Envestnet Asset Management Inc , Surface Ophthalmics Inc , Securities Exchange Commission , Wasatch Advisors Inc , Opaleye Management Inc , Harrow Health Inc , Prelude Capital Management , Pharmaceuticals Inc , Quarter For Harrow Health , Harrow Health Stock Down , News Ratings For Harrow Health Daily , Blackrock Inc , Get Free Report , Opaleye Management , Exchange Commission , Health Stock Down , Asset Management , Capital Management , State Street Corp , Street Corp , Surface Ophthalmics , Melt Pharmaceuticals ,

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Markl Baum , Harrow Health Trading , Institutional Trading Of Harrow Health , Blackrock Inc , Vanguard Group Inc , Pharmaceuticals Inc , Harrow Health , Opaleye Management Inc , Morgan Stanley , Insider Activity At Harrow Health , Securities Exchange Commission , Eton Pharmaceuticals Inc , Surface Ophthalmics Inc , News Ratings For Harrow Health Daily , Harrow Health Inc , Free Report , Exchange Commission , Opaleye Management , Get Free Report , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,

B. Riley Reaffirms "Buy" Rating for Harrow Health (NASDAQ:HROW)

B. Riley reissued their buy rating on shares of Harrow Health (NASDAQ:HROW – Get Rating) in a research note published on Thursday, PriceTargets.com reports. B. Riley also issued estimates for Harrow Health’s FY2026 earnings at $4.27 EPS and FY2027 earnings at $6.22 EPS. A number of other analysts also recently issued reports on the stock. […] ....

Harrow Health Inc , Harrow Health Stock , Harrow Health Company Profile , Tower Research Capital , Dorsey Wright Associates , Eton Pharmaceuticals Inc , Barclays Plc , Pharmaceuticals Inc , Surface Ophthalmics Inc , Northwestern Mutual Wealth Management Co , Harrow Health , News Ratings For Harrow Health Daily , Institutional Trading Of Harrow Health , Get Rating , Street Capital , Mutual Wealth Management , Research Capital , Captrust Financial Advisors , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Reiterated Rating , B Riley ,